TREM2 and Stroke: Recent data provides direct evidence of the beneficial effects of microglial phagocytosis, because transgenic silencing of the phagocytosis receptor TREM2 impairs microglial phagocytosis in vitro and exacerbates ischemic damage in experimental stroke [70].